Sage View Advisory Group, LLC Gilead Sciences, Inc. Transaction History
Sage View Advisory Group, LLC
- $2.35 Trillion
- Q1 2025
A detailed history of Sage View Advisory Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sage View Advisory Group, LLC holds 6,800 shares of GILD stock, worth $748,612. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,800
Previous 7,177
5.25%
Holding current value
$748,612
Previous $663 Million
14.95%
% of portfolio
0.03%
Previous 0.03%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,288Shares Held
997MCall Options Held
9.62MPut Options Held
10M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.9 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.55 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.01 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.9 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...